Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details